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Abstract     
In older populations, caregiving for a spouse with dementia has been associated with a 
poor antibody response to vaccination.  The present study examined whether younger 
caregivers, specifically the parents of children with developmental disabilities, would also 
show a diminished antibody response to vaccination.  At baseline assessment, 30 parents 
of children with developmental disabilities and 29 parents of typically developing children 
completed standard measures of depression, perceived stress, social support, caregiver 
burden, and child problem behaviours.  They also provided a blood sample and were then 
vaccinated with a pneumococcal polysaccharide vaccine.  Further blood samples were 
taken at 1- and 6-month follow-ups.  Caregivers mounted a poorer antibody response to 
vaccination than control parents at both follow-ups.  This effect withstood adjustment for a 
number of possible confounders and appeared to be, at least in part, mediated by child 
problem behaviours.  The negative impact of caregiving on antibody response to 
vaccination is not restricted to older spousal caregivers, but is also evident in younger 
parents caring for children with developmental disabilities. The behavioural characteristics 
of the care recipients may be a key consideration in whether or not immunity is 
compromised in this context.  
 
Keywords:  Antibody response; Caregiving; Children with developmental disabilities; 
Child problem behaviours; Chronic stress; Pneumococcal vaccination 
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    1. Introduction 
 
      Antibody response to vaccination provides a useful model for studying psychosocial 
influences on in vivo immune function (Burns et al., 2003a; Phillips and Burns, 2008; 
Vedhara et al., 1999a).  Stress, whether measured as life events exposure, perceived stress, 
or negative affect has been found to be inversely associated with the antibody response to 
a variety of medical vaccinations (Burns et al., 2003b; Burns et al., 2002; Gallagher et al., 
2008a; Marsland et al., 2001; Phillips et al., 2005; Phillips et al., 2006), implying that 
those experiencing stress have a reduced capacity to fight viral and bacterial infections.  In 
humans, the effects of chronic stress on immunity have mainly been studied by comparing 
non-routine caregivers and broadly matched controls (Kiecolt-Glaser et al., 1991; Kiecolt-
Glaser et al., 1987; Mills et al., 2004; Redwine et al., 2004; Vedhara et al., 1999b; 
Vitaliano et al., 1998).  There is now reasonable consensus that older spousal caregivers of 
dementia patients have a relatively poor response to both influenza and pneumococcal 
vaccinations (Glaser et al., 2000; Kiecolt-Glaser et al., 1996; Vedhara et al., 1999a).  
However, younger caregivers have rarely been studied in this context.   
 
      The only published vaccination study to target younger caregivers found no 
differences in antibody response to influenza vaccination between those caring for a 
spouse with multiple sclerosis and controls (Vedhara et al., 2002).  This raises the issue of 
whether the poor antibody response observed in older caregivers is, to an extent, a function 
of an interaction between chronic stress exposure and immuosenescence, and accordingly 
will be less likely to occur in younger caregivers (Graham et al., 2006; Kiecolt-Glaser et 
al., 2003).  Indeed, a recent study from our group supports such a notion (Gallagher et al., 
2008b).  S-IgA secretion rates were found to be lower in non-routine caregivers relative to 
controls, but only for the oldest of three distinct age cohorts.  Nevertheless, analysis within 
the caregiving group indicated that for the youngest and the middle-aged cohorts, S-IgA 
secretion rates varied negatively with caregiving burden and strain.   
       
      There is, however, an alternative explanation for the discrepancy in outcomes among 
the caregiver vaccination studies.  Rather than immuosenescence, it is possible that it is the 
intensity of the chronic stress experienced that determines whether caregiving becomes an 
issue for immunity (Vedhara et al., 2002).  Dementia is a disease characterised by much 
more severe cognitive and behavioural disturbances than multiple sclerosis (Gregory and 
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Hodges, 1996; Keegan and Noseworthy, 2002; Neary et al., 1998; Poser et al., 1983).  
Accordingly, the precise caregiving experience will vary between those caring for patients 
with multiple sclerosis and dementia.   Indeed, older spousal caregivers of dementia 
patients have been found to report greater distress than younger multiple sclerosis 
caregivers (Vedhara et al., 2002).  Further, the results of two recent meta-analyses indicate 
that caregivers of dementia patients generally experience greater burden and report more 
symptoms of depression than those caring for non-dementia, e.g., cancer patients, 
(Pinquart and Sorensen, 2003a, b).  Thus, it might be hypothesized that, irrespective of the 
caregiver’s age, caring for someone with severe cognitive and behavioural problems will 
compromise immunity.   
 
      A model which would allow us to shed light on these competing propositions is young 
parents caring for children with developmental disabilities.  Dealing with severe cognitive 
difficulties and behaviours that are problematic and distressing are the main challenges of 
such caring (Floyd and Gallagher, 1997; Hastings et al., 2006; Higgins et al., 2005; Maes 
et al., 2003).  Few previous studies have examined the impact of caregiver stress on 
immunity in relatively young caregivers per se, let alone in parents caring for a child with 
a developmental disability.  Table 1 provides a summary of the studies of young caregivers 
and the immune outcomes.  As can be seen, caregivers were daughters, mothers, adult 
children, and spouses.  Not all studies employed a case-control design and, in those that 
did, there were few differences between caregivers and controls in immune function.  
Exceptions were the observation that mothers of pre-term infants showed a poorer in vitro 
proliferative response to mitogens than mothers of full-term infants (Gennaro et al., 1997) 
and that mothers of children with cancer had lower glucocorticoid sensitivity than parents 
of healthy children (Miller et al., 2002).  For the most part, these studies examined the 
consequences for immunity of caring for someone with a physical rather than a mental 
health problem.  In only one was the care-recipient a child with an developmental 
disability; caregivers had a lower T helper: suppressor ratio than controls (Pariante et al., 
1997).  
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Table 1.  Caregiving and immunity in relatively young (< 60 years) caregiving samples 
 
Author Care recipient + 
carers 
       Age Psychological  
measures  
    Immune measures Results 
 CG        CO  
Baron et al., 
(1990) 
Cancer patients 
 + spouses  
48.2           - Depression, social 
support, life events  
Response to mitogens: Con 
A, PHA, NK activity and 
enumerative cell counts  
 
Within CG better social support =  greater proliferation to PHA, and NK 
activity  
Cohen & Pollack 
(2005) 
Mothers with breast 
cancer 
+ daughters 
37.5           - 
 
 
Emotional symptom 
checklist. Life disruption 
and  time helping 
 
Response to mitogens: 
PHA, LPS; IL-2, IL-12, 
cortisol and catecholamines  
Within CG: high distress  (advanced disease) = lower cytokines secretion   
 
Epel et al.,  
(2004) 
Chronically ill 
children  
+ mothers 
 Both groups  
       38 
Range 20-50 
 
Perceived stress and years 
since diagnosis 
(chronicity) 
Telomere length and 
telomerase function and 
oxidative stress 
Group differed only on stress 
Within CG, time caregiving  = shorter telomere length + lower activity and 
higher oxidative stress 
 
Gennaro et al., 
(1997) 
 
Preterm infants 
+ mothers 
27              24 Anxiety and depression  Response to mitogens: Con 
A, PHA and PWM and NK 
activity 
  
No difference in distress  
CG less responsive to mitogens  
Immune response ≠ to distress  
Miller et al., 
(2002) 
Children with 
cancer + parents 
36.5           37 Perceived stress, 
depression, affect and 
social support  
Cortisol , Glucocorticoid 
sensitivity, cytokines  
CG reported higher psychological distress  
No difference in baseline cytokine levels; CG had flatter cortisol slopes 
Reduced glucocorticoid sensitivity to IL-6, but not IL-1β or TNF-α 
CG sensitivity improved with tangible support 
 
Pariante et al., 
(1997) 
Developmentally 
disabled children 
+ mothers 
44              45 Burden, dependence 
behaviors, anxiety, 
depression and personality 
Enumerative cell 
count/ratios  
Humoral response to latent 
viruses  
CG more anxious 
CG less % of T-cells; higher ratio of T suppressor/cytotoxic cells; lower T 
helper/suppressor ratio.  
Age + severity of stress  -ve immunity  
 
Provinciali et al., 
(2004) 
 
Disabled older 
adults + adult 
children and 
grandchildren 
 
54              58 
 
Level of disability, 
depression, anxiety, stress,  
QoL , caregiver burden 
 
ACTH, cortisol, prolactin, 
NK activity and number, β-
endorphins. Incidence and 
severity of influenza  
 
 
No group effect 
CG unable to leave disabled person alone had lower NK count + activity   
 
 
Vedhara et al., 
(2002) 
Multiple Sclerosis 
patients + spouses 
46               33 Perceived stress, anxiety, 
depression and caregiver 
burden. 
Antibody response to 
influenza, IFN-γ and IL-4, 
cortisol and DHEA 
CG reported more stress.   
No differences in antibody or cytokine responses 
CO had higher cortisol   
 
CG (Care giver); CO (Control); = associated with; ≠ not associated with; -ve = negatively associated  
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      Although possible physiological mediators of the diminished antibody responses in elderly 
caregivers have received some attention (Kiecolt-Glaser et al., 1996; Li et al., 2007; Vedhara 
et al., 1999a), consideration of psychological and circumstantial mediators has been sparse 
(Vitaliano et al., 2003).  Research has identified caregiver burden as a potent contributor to 
psychological distress in various caregiver groups (Beach et al., 2000; Cooper et al., 2007; 
Garand et al., 2005).  For those parents caring for children with developmental disabilities, 
child problem behaviours emerge as an additional factor (Gallagher et al., in press,d; Hastings 
and Brown, 2002).  Further, perceived stress and depression have been associated with a 
reduced antibody response in older caregivers (Li et al., 2007), and caregivers almost 
invariably differ from controls in the social support they can draw on; those who are socially 
isolated appear to suffer poorer immunity (Baron et al., 1990; Kiecolt-Glaser et al., 1987).  
Consequently, it is possible that a poor antibody response to vaccination will be particularly 
evident in parental caregivers who are more distressed, socially isolated, burdened, and report 
more child problem behaviours.   
 
      The present study compared the responses to pneumococcal vaccination of relatively 
young parents caring for a child with a developmental disability and parents caring for a 
typically developing child.  As such, it is the only study that we know of that has examined 
antibody response to vaccination in parents caring for a child with a developmental disability.  
In addition, these particular caregivers provide an optimal model for testing whether the 
poorer antibody response to vaccination observed in older caregivers of dementia patients is 
specific or generalizes to younger caregivers with similar or even greater caregiving demands, 
i.e., is it the age of the caregiver that mainly matters or the characteristics of the care 
recipient?  Finally, by measuring psychological and caregiving characteristics of our 
participants in greater detail than previous caregiving studies, we also aspired to shed light on 
the psychosocial determinants of any impairment in antibody response in the present 
caregivers.  It was hypothesized that parents of children with developmental disabilities would 
report substantially more distress and exhibit a poorer antibody response.  We also explored 
whether it was distress, social support, burden, or the child’s problem behaviours that was 
most strongly associated with any impairment in vaccination response.   
 
2. Methods 
 
2.1. Participants  
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       Thirty-two parents caring for children with developmental disabilities and 29 parents of 
normally developing children attended the baseline session.  Developmental disability is the 
term used to describe conditions including but not limited to Autism spectrum disorders and 
Downs syndrome (National Institute of Child Health and Development, National Institute of 
Health- http://www.nih.gov/icd/).  These parental caregivers were recruited via invitation 
letters distributed by their respective associations and by advertising in syndrome newsletters, 
and by direct contact with family support groups.  Inclusion criteria for these parents were: 
caring for at least one child with Autism, Downs, Cornelia de Lange, or Smith-Magenis 
syndromes.  Since the emotional reaction of parental caregivers is highly influenced by the 
diagnostic process (Graungaard and Skov, 2007), we aimed to avoid this particular event and 
focus on the parents’ stressful experiences of caring per se.   Thus, in keeping with existing 
research (Hastings et al., 2006), children with developmental disabilities had to be aged 
between 3 and 19 years and living at home during the school term.  These children attended 
either ‘special needs’ schools or had ‘special need provision’ in main stream school.  The 
majority of parents reported caring for a child with Autism (66%); the remainder were caring 
for a child with Downs (22%) or with other syndromes (12%).  Controls, i.e. parents of 
typically developing children who were in the same age range as the disabled sample, were 
recruited via local schools, media campaigns and newspaper advertisements.  One caregiver 
parent reported that he had previously received the pneumococcal vaccine and was thus was 
excluded from participation.  No other parents had received the pneumococcal vaccine 
previously or had a history of negative reactions to blood sampling (e.g., fainting).  None 
reported suffering from a current acute infection, chronic medical condition, or immune 
disorder (e.g., glandular fever), or taking prescribed medication (excluding the contraceptive 
pill).  None of the female participants reported that they were pregnant.  Attempts were made 
to match the groups as closely as possible on age, sex, socioeconomic position, ethnicity, and 
marital status, by recruiting individual parents of normally developing children that matched 
as near as possible individual parents of children with developmental disabilities.  
 
2.2. Study design and procedure 
 
      This was a prospective case-control study involving three testing sessions: baseline, 1-
month and 6-month follow-up.  At baseline, parents completed questionnaires and then 
provided a blood sample to determine baseline antibody status.  After medical screening, they 
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were vaccinated with the 23-valent
 
polysaccharide pneumococcal (Pneumovax II; Sanofi 
Pasteur MSD) vaccine via subcutaneous injection in the upper arm.  Following vaccination, 
parents were asked to return one month later (mean lag = 31, SD = 4, days) and six months 
later (mean lag =183, SD = 5, days) to provide a further venous blood sample for 
measurement of antibody titre.  Antibody data were available for 59 participants at the first 
follow-up and 56 at the later follow-up. One caregiving parent relocated and was therefore 
unable to attend their next appointments; the remaining three parents who were not available 
for the final follow-up cited issues of family commitments as the main reason for non-
attendance.  The choice of follow-up times was dictated by wishing to capture both the peak 
IgG response and the subsequent decay. 
 
2.3. Questionnaires 
 
2.3.1. Depression  
    Parental depression was measured using the Hospital Anxiety and Depression Scale 
(HADS) (Zigmond and Snaith, 1983).  The scale contains 14 four-point items, from 0, not 
present, to 3, considerable, with seven assessing largely the anhedonic rather than somatic 
aspects of depression (e.g., ‘I have lost interest in my appearance’) and seven assessing 
anxiety (e.g., ‘I feel tense or wound up’).  The item scores were added to yield sub-scale 
scores for depression and anxiety from zero to 21.  In the present study, only the depression 
subscale was used.  The HADS has good concurrent validity (Bramley et al., 1988; Herrmann, 
1997).  For the present sample, Cronbach’s α was .86 for the depression subscale. 
 
2.3.2. Perceived stress 
    Psychological stress over the previous month was measured using the 14-item Perceived 
Stress Scale (Cohen et al., 1983).  This scale used extensively in caregiver research (Glaser et 
al., 2000; Vedhara et al., 2002), measures the degree to which individuals appraise situations 
in their lives as stressful over the last month.  Scale responses ranged from 0, never, to 4, very 
often, with higher scores indicating greater perceived stress.  This scale shows good test–retest 
reliability (r = .80) and internal reliability (Cronbach’s α = .75).  In the present study, a high 
internal consistency was observed, α = .88. 
 
2.3.3. Social support 
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     Social support was assessed using the 12-item Support Functions Scale (Dunst et al., 
1988).   Parents rated each source of support available to them including practical (e.g. 
‘someone to help take care of my child’) and emotional (e.g. ‘someone to talk to about things 
that worry me’) support on a 5-point Likert scale ranging from 1, never, to 5, quite often.  This 
scale has been shown to be reliable (Cronbach’s α = .86) and has been used previously in 
developmental disability research (White and Hastings, 2004).  A high internal consistency (α 
= .89) was also evident for the present sample. 
 
2.3.4. Caregiver Burden 
   As a measure of parental caregiver burden, an adapted version of the 22-item Caregiver 
Burden Index was used (Zarit et al., 1986).  This index was designed to assess the stresses 
experienced by family caregivers of elderly and disabled persons.  Questions were amended 
replacing ‘your relative’ with ‘your child’.  Examples of items include ‘Do you feel that 
because of the time you spend with your child that you don’t have enough time for yourself?’, 
‘Are you afraid what the future holds for your child?’, and ‘Overall, how burdened do you feel 
in caring for your child?’.  Responses ranged from 0, never, to 4, nearly always.  The scale has 
also been used previously in caregiver research (Vedhara et al., 2002).  Internal consistency in 
the current sample was .94. 
 
2.3.5. Child problem behaviour 
    The 25-item Strengths and Difficulties Questionnaire (Goodman, 1997), was used to 
screen for child problem behaviour.  The measure has five subscales, with one assessing 
prosocial behaviour (e.g. ‘kind to younger children’) and four assessing problem behaviour; 
emotional symptoms (e.g. ‘often unhappy, downhearted or tearful’), conduct disorder (e.g. 
‘often argumentative with adults’), hyperactivity (e.g. easily distracted, concentration 
wanders’), and peer relationships (e.g. rather solitary, tends to play alone’).  Parents are asked 
to rate whether a behaviour is 1, true, to 0, somewhat true or 2, certainly true, of their child 
with higher scores indicating more problem behaviour.  Some items are reversed scored (e.g. 
generally obedient, usually does what adults request).  The scale has been shown to be reliable 
(Cronbach’s α = .76) and effective at identifying behavioural problems in children (Goodman 
and Scott, 1999).  Further, it has been used extensively in research with children with 
developmental disabilities (Hastings et al., 2006).  Internal consistency for the whole scale in 
this study was .88.  For the purpose of our analyses both total and subscale scores were used.  
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2.4. Control and confounding variables  
     
    2.4.1. Health behaviours  
    As in our previous research (Burns et al., 2003a; Phillips et al., 2005; Phillips et al., 
2006) typical health behaviours were assessed at baseline, using a questionnaire adapted from 
the Whitehall II study (Marmot et al., 1991).  Participants were asked, on average how much 
they smoked (0, 1–5, 6–10, 11–20, and 21+ cigarettes per day); how much alcohol they drank 
(0, 1–5, 6-10, 11–20, 21–40, and 40 + units per week).  A simple categorical scoring method 
was used in all cases.  Participants were also asked how much time they spent in activities of 
light, moderate and vigorous exercise intensity which were summed to yield a composite 
exercise score.  They also indicated how regularly they ate certain foods from a standard list, 
and this information was summed to give a measure of fruit and vegetable consumption and 
fat intake.  
 
2.4.2. Sleep Quality  
  Sleep quality was measured by the 19-item Pittsburgh Sleep Quality Index (Buysse et al., 
1989).  This index has seven components including subjective sleep quality, sleep latency, 
sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medications, and 
daytime dysfunction with scores ranging from 0, no problems in area,  to 3, high problem 
area.  By summing component scores a total sleep quality score was obtained that ranges from 
0, good sleep quality, to 21, poor sleep quality. 
 
2.4.3. Time spent caregiving  
  Amount of time spent caregiving was assessed using a modified version of the Caregiver 
Activity Survey (Davis et al., 1997).  Rather than asking parents how much time they spend 
providing care each day to their child, this survey asks parents how much time on five specific 
(e.g. transport, dressing, eating, bathing and supervision) caring roles in any one day.  Hours 
for each caring role were summed together to yield a total daily score for time spent 
caregiving.  
 
2.5. Blood sampling and antibody analysis 
 
     Venous blood specimens were collected from an ante-cubital vein into two 7-ml plain 
tubes (BD Vacutainer, Meylan Cedex) to assess antibody titres.  Samples were allowed to clot 
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at room temperature for 1 h and centrifuged at 3500 rpm for 5 min.  The separated serum was 
frozen at −20°C until assayed.  Luminex technology was used to assess seven pneumococcal 
(Pn) IgG antibody serotypes (types 1, 3, 6, 9, 14, 19 and 23) contained in the pneumococcal 
vaccine.  Assessment and selection of these specific Pn serotypes were based on clinical 
observations linking these common serotypes to invasive disease in Europe (Denham and 
Clarke, 2005; Sleeman et al., 2001).  Further details of this assay are described elsewhere 
(Ferraro et al., 2008; Gallagher et al., 2008a; Lal et al., 2005).  Serum samples were diluted 
1:4000 in diluent buffer that additionally contained 5μg/ml purified pneumococcal serotype 
22F in accordance with the WHO protocol for ELISA detection of Pn antibody 
(http://www.vaccine.uab.edu/#), were run in duplicate, and read on a Luminex 100 machine 
(Luminex Corp, TX, USA).  Acquisition software (BioPlex Software Manager (version 4, 
BioRads, Labs, CA, USA) was used to generate serotype antibody concentrations from a 5 
parameter logistic curve fit.  Serum Pn IgG levels are reported in μg/L.  
 
2.6. Statistical analyses  
 
   Analysis of variance (ANOVA) and chi-square were employed to assess group 
differences in demographics, health behaviours, and psychosocial status.  Prior to statistical 
analyses, the antibody data were checked for assumptions of fit and normality.  Screening 
revealed two outliers and skewed antibody data.  One outlier (caregiver) was removed for the 
type 1 strain and one (control) for the type 23 strain and both were removed from the average 
titre.  These two participants registered biologically unfeasible values for at least one of the 
follow-ups.  For one, this took the form of registering a 700-fold increase in titre relative to a 
12-fold mean increase for the participants as a whole and for the other, an 80-fold increase 
relative to a 4-fold increase.  These exclusions are reflected in the slight variations in degrees 
of freedom.  Given the skew of the data, antibody titres were subjected to log10 transformation 
for the main analyses.  Partial eta- squared (η2p) is reported as a measure of effect size.  
Analysis of covariance (ANCOVA) was used to test for group differences in antibody titre at 
each follow-up separately; baseline antibody titre was always entered as a covariate.  We have 
used the analytic strategy of representing antibody response as the follow-up antibody titre 
adjusted for the baseline titre throughout our previous studies (Gallagher et al., 2008a, 2008c; 
Phillips et al., 2005; Phillips et al., 2006).  The approach of analyzing the two follow-ups 
separately is also identical to the one we have used in previous vaccination research 
(Gallagher et al., 2008a, 2008c; Phillips et al., 2005; Phillips et al., 2006).  It was in this case 
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further justified by the results of Glaser et al., (2000), who found caregiver control differences 
only at six months following vaccination, and by, in a small study with some attrition, our 
desire to optimize our degrees of freedom and hence our power to detect effects.  Where 
significant group effects emerged, subsequent ANCOVAs were undertaken to adjust for 
potential confounding variables.  The major dependent variables were the average IgG titres 
of the seven strains at the two follow-ups.  However, sensitivity analyses using the seven 
individual Pn polysaccharide serotypes were also undertaken.  A clinically adequate response 
to the 23-valent pneumococcal vaccine has been determined as a two-fold or greater rise in 
aggregate antibody titre (Center for Disease Control, 1989).  For illustration purposes, this 
criterion was adopted and the number of non-responders in each group compared using chi-
square.  Hierarchical linear regression analyses were used to determine whether any of the 
caregiving or psychosocial variables predicted log10 antibody level at each follow-up.  In these 
regression models, antibody levels at baseline were entered at step one, parental groups at step 
2 and caregiving and psychosocial variables entered separately at step three.  Mediation 
analysis was then conducted to determine whether the caregiving or psychosocial variables 
mediated any variation between groups in antibody response.   
 
3. Results  
 
3.1. Demographic, childcare and psychosocial characteristics of parental groups 
 
      The demographic and summary childcare characteristics of the two parental groups are 
presented in Table 2.  It is evident that the groups are reasonably well matched on most 
variables.  However, parents of children with developmental disabilities were slightly older on 
average, their child was older; they were less likely to be currently employed outside the home 
and spent more time caregiving.  They also reported poorer sleep quality.  Where appropriate, 
the analyses adjusted for these variables.  There were no differences between groups in health 
behaviours such as alcohol consumption and smoking.   As might be expected, parents caring 
for a child with a developmental disability had much higher levels of depressive 
symptomatology and perceived stress, reported poorer social support, greater caregiving 
burden, and more child problem behaviour than parents of typically developing children (see 
Table 2) 
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           Table 2. Demographics, childcare and psychosocial characteristics of each parental group  
 
 
 Caregivers  
(N = 30) 
Controls  
(N = 29) 
Test of difference 
    
Sex (Female) 23 (76%) 20 (69%) χ2 (1) = 0.14, p = .70 
Marital status (Partnered) 26 (87%) 20 (70%) χ2 (1) = 1.76, p = .19 
Ethnicity (Caucasian) 29 (91%) 26 (90%) χ2 (1) = 0.00, p = 1.00 
Occupational status (Professional) 14 (47%) 16 (55%) χ2 (1) = 0.15, p = .70 
Employed outside the home   22 (73%) 28 (96%) χ2 (1) = 6.56, p = .005 
Alcohol (1-20 units per week) 28(100%) 25(93%) χ2 (1) = 0.557, p = .45 
Smoking (non- smoker) 23 (93%) 25 (79%) χ2 (1) = 1.08, p = .30 
Body Mass Index (SD) 26.7 (4.33) 24.7 (4.10) F (1,54) = 2.91, p =.09 
Hours caregiving (SD) per day 10.6 (8.19) 3.5 (3.53) F (1,56) = 17.89, p <.001 
Sleep quality (SD) 10.0 (2.55) 7.1 (2.09) F (1,57) = 23.08, p <.001 
Mean age (SD) years 42.8 (5.95) 39.9 (4.35) F (1,57) = 4.44, p = .04 
Mean age of child (SD) years 11.5 (3.41) 8.8 (4.22) F (1,57) = 7.18, p = .01 
Mean depression score (SD) 8.4 (3.86) 3.2 (2.31) F (1,57) = 38.40, p <.001 
Mean stress score (SD)  30.33 (8.40) 22.2 (7.48) F (1,57) = 15.52, p <.001 
Mean social support score (SD) 31.7 (9.82) 37.9(10.37) F (1,57) = 5.62 , p =.02 
Mean burden score (SD)  44.0 (14.26) 22.9 (10.67) F (1,57) = 40.94, p <.001 
Mean behaviour problem score (SD) 23.0 (5.97) 9.9 (4.89) F (1,57) = 84.64, p <.001 
 
  
3.2. Antibody response to vaccination  
 
   The mean (SE) actual antibody levels (μg/L) for the average pneumococcal titre, and for 
each of the seven targeted individual strains, at each time point for each of the groups is 
displayed in Table 3.  The average antibody titre rose from baseline to 1-month follow-up for 
both groups and, although there was some subsequent decline, antibody levels were still 
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higher at the 6-month follow-up than at baseline.  A broadly similar pattern was observed for 
each of the individual strains for each of the groups.  There was no significant difference 
between groups in average pneumococcal titre at baseline, but baseline antibody levels were 
higher in the caregivers for the type 3 and type 19 strains. 
 
 
 
Table 3.  Mean (SE) antibody titres (ug/L) for the average and the individual pneumococcal 
serotypes at baseline, 1-month and 6-month follow-up.  
 
Pneumococcal 
titre 
Baseline 1-Month 6-Month 
 
Caregivers  
 
Controls 
 
Caregivers 
 
Controls 
 
Caregivers 
 
Control 
Average  
 
327 
(82) 
 
201 
(99) 
856 
(109) 
937 
(111) 
576 
(76.9) 
847 
(78.3) 
Type 1
 
 
 
42 
(19) 
 
14 
(2) 
162 
(157) 
534 
(157) 
132 
(99) 
353 
(99) 
Type 3
 
 
 
 22
 a
 
(8) 
 
4 
(1) 
63 
(24) 
78 
(25) 
42 
(24) 
72 
(25) 
Type 6
 
 
 
1125 
(328) 
 
1052 
(674) 
1823 
(396) 
2355 
(411) 
1021 
(282) 
1539 
(294) 
Type 9
 
 
 
135 
(80) 
 
23 
(11) 
285 
(62) 
390 
(63) 
169 
(52) 
302 
(53) 
Type 14
 
 
 
598 
(274) 
 
189 
(70) 
2004 
(417) 
1899 
(424) 
1732 
(298) 
1669 
(304) 
Type 19
 
 
 
  181
 a
 
(59) 
 
43 
(17) 
788 
(244) 
542 
(248) 
556 
(144) 
537 
(147) 
Type 23
 
 
 
134 
(59) 
 
34 
(9) 
332 
(83) 
363 
(86) 
199 
(66) 
319 
(69) 
 
a
 Significant difference (p < .05) between caregivers and controls at baseline.  The follow-up 
titres are adjusted for baseline. 
 
 
3.3. Caregiving and antibody response  
 
    After adjusting for baseline log10 antibody levels, the aggregate log10 antibody titre at 
both follow-ups differed significantly between parental groups.  Parents caring for children 
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with developmental disabilities had a much poorer antibody response than parents of typically 
developing children, at both the 1-month, F(1, 57) = 5.65, p = .02, η2p
 
= .095, and the 6-month 
follow-up, F(1, 50) = 7.14, p = .01, η2p 
 
= .125.  The η2p values signify medium to large effects 
(Cohen, 1988; Pierce et al., 2004).   A repeated measures ANCOVA, with both follow-ups 
included, confirmed these group differences, F(1, 50) = 6.86, p = .01, η2p 
 
= .121.  As an 
indicator of a clinically protective antibody response, a two-fold increase in antibody titre 
from baseline to follow-up was used; individuals not achieving a two fold response were 
classified as non-responders.  Parents of children with developmental disabilities were more 
likely to be non-responders than parents of typically developing children at both the 1-month 
(20% versus 4%) and the 6-month (48% versus 4%) follow-up (see Figure 1).  Health 
behaviours including smoking, diet, exercise, and alcohol consumption were unrelated to 
antibody response.  It is thus unsurprising that the differences reported above withstood 
adjustment for these variables in ANCOVA.  Further, because age of parents and care 
recipient, work outside the home, time caregiving and sleep quality differentiated groups, 
these were also entered as covariates.  The main outcomes also remained unchanged following 
adjustment for these variables.   
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  Figure 1.  Percentage of non-responders (less than two-fold increase) from baseline at 1-
month follow-up (a) and from baseline to 6-month follow-up (b) for each parental group 
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3.4. Sensitivity analysis for caregiving and antibody response to individual strains  
 
    Sensitivity analysis was undertaken to establish which pneumococcal serotypes differed 
between parental groups.  At both follow-ups, parents of children with developmental 
disabilities had a poorer response to the type 1 strain, F (1, 55) = 6.97, p =.01, η2p = .112, and 
F (1, 51) = 6.68, p =.02, η2p = .100, respectively, and the type 6 strain, F (1, 55) = 4.59, p 
=.04, η2p = .112 and F (1, 51) = 12.57, p >.001, η
2
p = .198, respectively.  At 6-month follow-
up, the group difference in response to type 3 strain approached significance, F (1, 52) = 3.62, 
p =.06, η2p = .065, with parental caregivers tending to mount a poorer response.   
 
3.5. Contribution of depression, perceived stress, social support, caregiver burden and child 
problem behaviour to group differences in antibody titre 
 
   In hierarchical linear regression analysis in which baseline titre was entered at step 1 and 
parental group at step 2, and each psychosocial variable entered individually at step 3, only 
child problem behaviour, β = -.29, t = 2.33, p =.02, ΔR2 = .03, abolished the between group 
effect for the 1-month antibody response.  In these analyses, the β for parental group changed 
from -.20 at step 2 to .04 at step 3.  Accordingly, we tested for mediation using the Goodman 
test (Goodman, 1960).  This revealed evidence of mediation, z = 3.09, p <.001.  Thus, it 
would seem that child problem behaviour was not only associated with the 1-month antibody 
titre independently of parental group in this model, but also appeared to account for the 
caregiver/control group differences in antibody response.  The outcome of the mediation 
analysis is presented in Figure 2.  Further, analysis of the questionnaire subscales indicated 
that it was conduct behaviours that were primarily responsible; the β for parental group 
changed from -.20 at step 2 to -.09 at step 3.  Similar analyses were undertaken with the 6-
month antibody titre as the dependent variable.  In these analyses no associations emerged 
between the psychosocial variables and antibody titre.  In addition, the associations reported 
above withstood adjustment for demographic variables, other caregiving variables, and health 
behaviours, including sleep quality.  
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Figure 2. Mediation analysis of the association between parental group and 1-month 
antibody titre for child problem behaviour; statistics are standardized regression 
coefficients adjusted for baseline antibody titre. 
 
3.6. Within case group antibody analyses  
 
       In hierarchical linear regression analyses, again adjusting for baseline titre, no significant 
associations emerged between any of the psychosocial variables and antibody response of 
parents caring for a child with developmental disabilities.  However, although not meeting the 
conventional criterion for statistical significance, there were indications of a negative 
association between child problem behaviour and 1-month antibody response, β = -.19, t = 
1.57, p = .12, ΔR2 = .04.  Again, it was conduct problems that tended to be associated 1-month 
antibody response, β = -.20, t = 1.61, p = .12, ΔR2 = .04.  Moreover, when these parents were 
divided into those reporting high and low conduct problems in their children using a median 
split, ANCOVA revealed a significant effect, F (1, 25) = 4.51, p = .04, η2p
 
= .153; parents 
caring for a child with developmental disabilities who reported that their children showed 
more conduct problem behaviours mounted a poorer antibody response at 1-month (see Figure 
3).  No associations emerged between any of the psychosocial and circumstantial factors for 
the 6-month antibody titre. 
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Figure 3.  Mean (SE) antibody titre at 1-month follow-up, adjusted for baseline antibody 
titre, for parents of children with developmental disabilities with high and low reported 
conduct behaviour problems.   
 
4. Discussion  
 
    Parents caring for children with developmental disabilities exhibited a poorer antibody 
response to a pneumococcal vaccination than parents caring for typically developing children 
at both 1-month and 6-month follow-ups.  Of the variables considered it would appear to be 
child problem behaviour which mediated this effect.  In addition, within the parental 
caregiving group, parents reporting more child conduct problems, a component of the child 
problem behaviour measure, mounted a poorer antibody response at 1-month than parents 
reporting less conduct problems.  
 
     Adopting the criterion of a two-fold antibody response as indicative of clinical 
protection, 20% of parents caregiving for a child with a developmental disability failed to 
mount an adequate response compared to only 4% of controls at 1-month follow-up.  At 6-
months, almost half (48%) did not meet the two-fold criteria compared with 4% of controls.  
Thus, a negative impact of caregiving on vaccination response would not appear to be 
 19 
restricted to older individuals caring for spouses with dementia (Glaser et al., 2000; Kiecolt-
Glaser et al., 1996; Vedhara et al., 1999a), and, accordingly, would not seem to require an 
ageing immune system in order to manifest itself.  Rather, our results suggest that it is the 
characteristics of the caregiving experience per se that is the key determinant of its impact on 
immunity.  Variations in caregiving experience could also explain the discrepancy in 
outcomes between the present study and the earlier finding that younger spousal caregivers of 
multiple sclerosis patients did not differ from controls in antibody response (Vedhara et al., 
2002).  A cursory comparison of the two studies reveals that the present caregivers reported 
much higher perceived stress (Mean 30.33 +  8.40) and caregiver burden (Mean 44.0 + 14.26), 
than those caring for spouses with multiple sclerosis (Mean 25.42 +  8.45) and (Mean 29.00 + 
14.80) respectively, t (70) = 2.46, p =.01, and, t (70) = 4.31, p <.001.  Although neither 
perceived stress nor caregiver burden accounted for the differences between groups in 
antibody responses they correlated highly with child behaviour problems in the sample as a 
whole, as well as within the caregiving group (r = .49 to .76).  It is also possible that 
differences in vaccination, pneumococcal versus influenza, might also have contributed to the 
differences in results.  However, it is worth noting that responses to both vaccinations have 
been found to be compromised in those caring for spouses with dementia (Glaser et al., 2000; 
Kiecolt-Glaser et al., 1996; Vedhara et al., 1999a).  
 
    The present study is not only the first to study caregivers of children with developmental 
disabilities in this context, it is also only the second to examine the responses of caregivers to 
pneumococcal vaccination.   In the previous study, older spousal caregivers showed a poorer 
response to pneumococcal vaccination relative to former caregivers and non-caregiving 
controls, but only at the final 6-month follow-up (Glaser et al., 2000).  Although, the 
difference between caregivers and controls in the present study was larger at the later follow-
up, the groups still differed significantly at the earlier 1-month follow-up.  More demanding 
caregiving could again provide an explanation for the earlier effect in the present study.  In 
support of this, perceived stress, measured on the truncated scale, was much higher among the 
present parental caregivers than that reported for the spousal caregivers of patients with 
dementia (Mean 22.23 +  7.27 versus Mean 16.73 +  2.82), t (39) = 3.52, p <.001. Again 
caution is warranted, since perceived stress did not account for the differences between groups 
in vaccination response.   
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    In analyses of the individual pneumococcal IgG antibody serotypes, parents of children 
with developmental disabilities mounted a poorer response to type 1 and type 6 strains at both 
follow-ups, and to type 3 at 6-months.   It appears that some Pn serotypes are more susceptible 
to psychosocial influence.  Such specificity has also been reported from other studies using 
polyvalent vaccinations (Phillips et al., 2005; Phillips et al., 2006; Pressman et al., 2005; 
Vedhara et al., 1999a).  Indeed, in a recent study of students, social support was associated 
with antibody response to pneumococcal vaccination and it was types 1 and 3 again which 
appeared to be particularly sensitive (Gallagher et al., 2008a; 2008c).  One explanation for 
such specificity is that antigens that are less immunogenic are more susceptible to exogenous 
influence (Cohen et al., 2001).  It is worth noting in this regard that some of the smallest 
antibody titres at follow-up were observed for the types 1 and 3 strains.   
 
    We also explored whether it was distress, social support, burden or the child’s problem 
behaviour that was most strongly associated with any impairment in vaccination response.  
Despite group differences on all psychosocial and circumstantial measures, no associations 
emerged between depression, perceived stress, social support, or caregiver burden and 
antibody responses at either follow-up.  However, child problem behaviour was a significant 
predictor of 1-month antibody response and a formal test of mediation confirmed it as a 
candidate mediator.  Thus, it appears that child problem behaviour was not only associated 
with antibody titre independently of parental group, but also contributed substantially to the 
caregiver/control group differences in the antibody response.  In addition, subscale analysis 
indicated that conduct behaviours (e.g., often has temper tantrums, often fights with other 
children) were primarily responsible for this effect.  Further, within the caregiving group, 
those parents reporting more problems with conduct behaviour showed a poorer response to 
vaccination compared to those reporting less conduct behaviours.  The negative association 
between care recipients’ problem behaviour and antibody responses is broadly in line with the 
results of research on caregivers of patients with mental health difficulties using other health 
outcomes.  For example, not only have problem behaviours been associated with caregivers’ 
psychological distress (Mausbach et al., 2006; Pinquart and Sorensen, 2003a, b), they have 
also been linked to increased incidence of infectious illness (Dyck et al., 1999) and the onset 
of cardiovascular disease (Mausbach et al., 2007).  The current findings reinforce the 
importance of targeting child problem behaviours in interventions for those caring for a child 
with a developmental disability.  There is preliminary evidence that managing behaviour 
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problems in dementia patients can enhance caregivers’ in vitro immunity immediately after 
intervention and 6-months later (Garand et al., 2002).    
 
    The current study has a number of limitations.  First, our sample size might be regarded 
as small.  Nevertheless, it is of a similar order of magnitude to that of other published case-
control studies (Glaser et al., 2000; Vedhara et al., 2002).  Second, it is possible that our 
sample was biased and included more parents from support groups, who were particularly 
stressed.  However, contacted but non-participating parents almost invariably cited 
geographical distance from the University, or an unwillingness to give blood or receive a 
vaccination as their reasons for not participating.  Third, there were group differences in 
baseline titre, but these were not significant for the average pneumococcal titre or for five of 
the seven strains.  There has been speculation on the effects or prior antigenic exposure on 
subsequent capsular polysaccharide vaccination responsiveness, with some studies finding 
higher antibody concentration and others lower (see Artz, et al., 2003; Davison et al., 1994; 
O’Brien et al., 2007).  Importantly, in the present study, the strains that differed significantly 
between groups in vaccination response (types 1 and 6) were not among those showing a 
significant group difference at baseline.  Thus, our results for vaccination response are 
unlikely to be an artifact of baseline antibody status.  Fourth, there is also the possibility of 
confounding as a result of unmeasured or poorly measured variables.  However, our main 
findings survived statistical adjustment for the more common health behaviours and any group 
differences that emerged as a result of imperfect matching.  Finally, in the absence of 
appropriate measurement we can only speculate about underlying biological mechanisms.  
Nevertheless, in caregivers of dementia patients a higher cortisol awakening response was 
found for those reporting high versus low levels of behavioral problems in the care recipients 
(de Vugt et al., 2005).  Further, secretion of this stress hormone was inversely associated with 
antibody response to influenza vaccination in caregivers of dementia patients (Vedhara et al., 
1999b).  Such variations in cortisol may provide one pathway through which problem 
behaviours exert an influence on antibody response to vaccination.  
 
    In conclusion, the negative impact of caregiving on antibody response to vaccination is 
not restricted to older spousal caregivers, but is also evident in younger parents caring for 
children with developmental disabilities.  Relative to parents of typically developing children, 
such caregivers mounted a poorer response than controls to a pneumococcocal vaccine at 1-
month and showed poorer maintenance at 6-months.   The strongest and most consistent 
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predictor of group differences in antibody response, as well as individual variations in 
response within the group of parents of children with developmental disabilities, was child 
problem behaviour.  Analyses of its subscales indicated that it was conduct behaviours that 
underlay these effects.  Thus, the behavioural characteristics of the care recipients may be a 
key determinant of whether or not immunity is compromised in this context.   
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